Purvalanol B

CAS : 212844-54-7

Ref. 3D-MIA84454

Informations sur le produit

• Nom: Purvalanol B
• Marque: Biosynth
• Description: Purvalanol B is a selective cyclin-dependent kinase (CDK) inhibitor, which is synthetically derived through chemical synthesis. With high specificity, it inhibits CDK activity by competitively binding to the ATP-binding site of these kinases, thereby blocking substrate phosphorylation and subsequent cell cycle progression. Purvalanol B's mechanism of action allows it to interfere with CDK-dependent processes, making it a valuable tool in elucidating cell cycle dynamics and the molecular underpinnings of cancer proliferation.

Propriétés chimiques

• Masse moléculaire: 432.9 g/mol
• Formule: C₂₀H₂₅ClN₆O₃
• Degré de pureté: Min. 95%